| Literature DB >> 35232786 |
Diego Enrique Vélez-Gómez1, Natalia Torres-Vellojín2, Juan Camilo Grajales-Zapata2, Juan Guillermo McEwen-Ochoa2,3, Alonso Martínez2, Verónica Ramírez-Lopera2, Aracelly Villegas-Castaño2.
Abstract
OBJECTIVE: To determine the prevalence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) in the homeless population in Medellín, Colombia, using molecular diagnostic methods. It also intended to develop a demographic profile, exploring associated factors and the dynamics of the social and sexual interactions of this community.Entities:
Keywords: epidemiology; infectious diseases; molecular diagnostics; public health
Mesh:
Year: 2022 PMID: 35232786 PMCID: PMC8889321 DOI: 10.1136/bmjopen-2021-054966
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Characteristics of all participants
| Variables | n (%) |
| Sex | |
| 352 (70.4) | |
| 148 (29.6) | |
| Age | |
| 50 (10.0) | |
| 162 (32.4) | |
| 146 (29.2) | |
| 75 (15.0) | |
| 59 (11.8) | |
| 7 (1.4) | |
| 1 (0.2) | |
| Gender identity | |
| 422 (84.4) | |
| Birthplace | |
| 279 (55.8) | |
| 221 (44.2) | |
| Marital status | |
| 341 (68.2) | |
| 94 (18.8) | |
| 25 (5.0) | |
| 40 (8.0) | |
| Highest educational level (grades) | |
| 33 (6.6) | |
| 177 (35.4) | |
| 158 (31.6) | |
| 100 (20.0) | |
| 21 (4.2) | |
| 10 (2.0) | |
| 1 (0.2) | |
| Children, n | |
| 197 (39.4) | |
| 208 (41.6) | |
| 64 (12.8) | |
| 31 (6.2) | |
| Source of income* | |
| 217 (43.4) | |
| 126 (25.2) | |
| 114 (22.8) | |
| 78 (15.6) | |
| 54 (10.8) | |
| 54 (10.8) | |
| 46 (9.2) | |
| 11 (2.2) | |
| 38 (7.6) | |
| Daily psychoactive substance consumption* | |
| 300 (60.0) | |
| 234 (46.8) | |
| 312 (62.4) | |
| 122 (25.6) | |
| 57 (11.4) | |
| 55 (11.0) | |
| 11 (2.2) | |
| 42 (8.4) | |
| 48 (9.6) | |
| Sexual partners in lifetime | |
| 20 (4.0) | |
| 381 (76.2) | |
| 45 (9.0) | |
| 54 (10.8) | |
| Sexual partners in the last 6 months | |
| 22 (4.4) | |
| 426 (85.2) | |
| 35 (7.0) | |
| 17 (3.4) | |
| Age of first sexual activity | |
| 5 (1.0) | |
| 58 (11.6) | |
| 253 (50.6) | |
| 184 (36.8) | |
| Use of contraception* | |
| 56 (37.8) | |
| 55 (37.2) | |
| 42 (28.4) | |
| 8 (5.4) | |
| 4 (2.7) | |
| 2 (1.4) | |
| 28 (18.9) | |
| 260 (73.9) | |
| 92 (26.1) | |
| Condom use in the last 3 months* | |
| 204 (40.8) | |
| 296 (59.2) | |
| 173 (58.4) | |
| 203 (68.6) | |
| Consent in past sexual encounters | |
| Females | |
| 64 (43.2) | |
| 67 (45.3) | |
| 17 (11.5) | |
| 41 (11.6) | |
| 284 (80.7) | |
| 27 (7.7) | |
| Frequency of intercourse | |
| 44 (8.8) | |
| 37 (7.4) | |
| 115 (23.0) | |
| 187 (37.4) | |
| 73 (14.6) | |
| 44 (8.8) | |
*Survey respondents could choose more than one option.
†Methylenedioxymethamphetamine (MDMA), commonly known as ecstasy or molly.
Figure 1Prevalence of gonorrhoea and chlamydia infections by gender.
Factors associated with Chlamydia trachomatis infection—OR
| Variable | Unadjusted OR | P value | ||||
| Positive | Negative | |||||
| n | % | n | % | |||
| Sex | ||||||
| Female | 45 | 46.9 | 103 | 25.5 | 2.58 (1.63 to 4.08) | <0.001 |
| 51 | 53.1 | 301 | 74.5 | |||
| Children | ||||||
| 71 | 74 | 232 | 57.4 | 2.11 (1.28 to 3.46) | 0.003 | |
| 25 | 26 | 172 | 42.6 | |||
| Has been taught how to use a condom | ||||||
| 20 | 20.8 | 44 | 10.9 | 2.15 (1.2 to 3.86) | 0.009 | |
| 76 | 79.2 | 360 | 89.1 | |||
| Consumption of glue/inhalant during intercourse | ||||||
| 13 | 13.5 | 25 | 6.2 | 2.37 (1.17 to 4.84) | 0.015 | |
| 83 | 86.5 | 379 | 93.8 | |||
| MDMA (ecstasy, molly) consumption during intercourse* | ||||||
| 10 | 10.4 | 18 | 4.5 | 2.49 (1.11 to 5.59) | 0.022 | |
| 86 | 89.6 | 386 | 95.5 | |||
| Consumption of cocaine during intercourse | ||||||
| 6 | 6.3 | 8 | 2 | 3.30 (1.12 to 9.75) | 0.023 | |
| 90 | 93.8 | 396 | 98 | |||
| Frequent irritation or discomfort symptoms | ||||||
| 9 | 9.4 | 16 | 4 | 2.51 (1.07 to 5.86) | 0.029 | |
| 87 | 90.6 | 388 | 96 | |||
| Condom use with casual partner | ||||||
| 41 | 62.1 | 128 | 47.9 | 1.18 (1.03 to 3.09) | 0.039 | |
| 25 | 37.9 | 139 | 52.1 | |||
| Domestic violence | ||||||
| 29 | 35.4 | 91 | 24.3 | 1.70 (1.02 to 2.84) | 0.040 | |
| 53 | 64.6 | 283 | 75.7 | |||
| Number of sexual partners in lifetime | ||||||
| 16 | 17.2 | 38 | 9.8 | 1.91 (1.01 to 3.6) | 0.043 | |
| 77 | 82.8 | 349 | 90.2 | |||
| Urethral discharge | ||||||
| 6 | 11.8 | 15 | 5 | 2.54 (0.94 to 6.89) | 0.059 | |
| 45 | 88.2 | 286 | 95 | |||
| Consent in past sexual encounters | ||||||
| 25 | 30.5 | 80 | 21.4 | 1.61 (0.95 to 2.74) | 0.076 | |
| 57 | 69.5 | 294 | 78.6 | |||
| Sleeping in a homeless care centre | ||||||
| 84 | 87.5 | 322 | 79.7 | 1.78 (0.93 to 3.42) | 0.079 | |
| 12 | 12.5 | 82 | 20.3 | |||
| Heroin consumption | ||||||
| 9 | 9.4 | 19 | 4.7 | 2.10 (0.92 to 4.79) | 0.074 | |
| 87 | 90.6 | 385 | 95.3 | |||
| Sexual partners in the last 6 months | ||||||
| 6 | 6.6 | 11 | 2.8 | 2.41 (0.87 to 6.71) | 0.082 | |
| 85 | 93.4 | 376 | 97.2 | |||
| Condom use | ||||||
| 39 | 40.6 | 145 | 35.9 | 1.22 (0.78 to 1.93) | 0.387 | |
| 57 | 59.4 | 259 | 64.1 | |||
| Has had Syphilis in their lifetime | ||||||
| 24 | 25 | 83 | 20.5 | 1.29 (0.77 to 2.17) | 0.339 | |
| 72 | 75 | 321 | 79.5 | |||
| Sex work | ||||||
| 12 | 12.5 | 42 | 10.4 | 1.23 (0.62 to 2.44) | 0.550 | |
| 84 | 87.5 | 362 | 89.6 | |||
| Cannabis consumption | ||||||
| 60 | 62.5 | 294 | 72.8 | 0.62 (0.39 to 1.00) | 0.047 | |
| 36 | 37.5 | 110 | 27.2 | |||
*Methylenedioxymethamphetamine (MDMA), commonly known as ecstasy or molly.
Factors associated with Neisseria gonorrhoeae infection—OR
| Variable | Unadjusted | P value | ||||
| Positive | Negative | |||||
| N | % | N | % | |||
| Gender identity | ||||||
| Transgender | 6 | 5.3 | 4 | 1 | 5.37 (1.49 to 19.37) | 0.00 |
| Non-transgender people | 107 | 94.7 | 383 | 99 | ||
| Last Pap Smear test | ||||||
| >1 year ago | 30 | 81.1 | 64 | 61.5 | 2.68 (1.08 to 6.67) | 0.03 |
| <1 year ago | 7 | 18.9 | 40 | 38.5 | ||
| Place for personal hygiene | ||||||
| Public place | 107 | 94.7 | 341 | 88.1 | 2.41 (1.00 to 5.79) | 0.04 |
| House, apartment | 6 | 5.3 | 46 | 11.9 | ||
| Had sexual contact while having an STI | ||||||
| Yes | 24 | 57.1 | 57 | 36.3 | 2.34 (1.17 to 4.67) | 0.02 |
| No | 18 | 42.9 | 100 | 63.7 | ||
| Frequency of intercourse | ||||||
| Daily | 15 | 13.3 | 22 | 6.4 | 2.23 (1.12 to 4.47) | 0.02 |
| Once a week or less | 98 | 86.7 | 321 | 93.6 | ||
| Sexual partners in the last 6 months | ||||||
| | 19 | 17.3 | 33 | 9 | 2.12 (1.15 to 3.90) | 0.01 |
| | 91 | 82.7 | 335 | 91 | ||
| HIV | ||||||
| Positive | 6 | 5.3 | 10 | 2.6 | 2.11 (0.75 to 5.95) | 0.09 |
| Negative | 107 | 94.7 | 377 | 97.4 | ||
| Type of sexual intercourse (last time) | ||||||
| Oral and/or anal | 17 | 15 | 31 | 8 | 2.03 (1.08 to 3.83) | 0.03 |
| Vaginal | 96 | 85 | 356 | 92 | ||
| Sleeping in a homeless care centre | ||||||
| Yes | 99 | 87.6 | 307 | 79.3 | 1.84 (1.00 to 3.40) | 0.05 |
| No | 14 | 12.4 | 80 | 20.7 | ||
| Number of sexual partners in lifetime | ||||||
| | 18 | 16.1 | 36 | 9.8 | 1.77 (0.96 to 3.25) | 0.07 |
| <100 | 94 | 83.9 | 332 | 90.2 | ||
| Sex work | ||||||
| Yes | 17 | 15 | 37 | 9.6 | 1.68 (0.90 to 3.11) | 0.10 |
| No | 96 | 85 | 350 | 90.4 | ||
| Last sexual contact | ||||||
| Commercial sex | 27 | 23.9 | 66 | 17.1 | 1.53 (0.92 to 2.54) | 0.10 |
| Stable or casual | 86 | 76.1 | 321 | 82.9 | ||
| Domestic violence | ||||||
| Yes | 35 | 31 | 85 | 24.8 | 1.36 (0.85 to 2.18) | 0.20 |
| No | 78 | 69 | 258 | 75.2 | ||
| Sex | ||||||
| Female | 38 | 33.6 | 110 | 28.4 | 1.28 (0.82 to 2.00) | 0.29 |
| Male | 75 | 66.4 | 277 | 71.6 | ||
STI, sexually transmitted infection.
Factors associated with Chlamydia trachomatis and Neisseria gonorrhoeae infection—Adjusted OR
| Bacteria | Risk factor | B | P value | Adjusted OR |
|
| Sexual intercourse while having an STI | 1.16 | 0.00 | 3.19 (1.48 to 6.85) |
| 1.07 | 0.04 | 2.91 (1.04 to 8.09) | ||
| Daily sexual relations | 1.15 | 0.05 | 3.15 (1.02 to 9.74) | |
|
| Being a woman | 0.88 | 0.00 | 2.42 (1.31 to 4.47) |
| No condom use with casual partners | 0.44 | 0.13 | 1.56 (0.87 to 2.77) | |
| Children | 0.42 | 0.17 | 1.52 (0.83 to 2.78) | |
| >100 sexual partners in lifetime | 0.42 | 0.26 | 1.52 (0.73 to 3.14) |
STI, sexually transmitted infection.